AN
Abdulpari Noorjahan
About Abdulpari Noorjahan
Data last updated:
Abdulpari Noorjahan is a Director at Biofocus Scientific Solutions Private Limited (since 2021) and Director at Future Biologics Private Limited (since 2026). The companies operate in Research & Development. The largest current company by reported revenue is Biofocus Scientific Solutions Private Limited at ₹18.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biofocus Scientific Solutions Private Limited U73200TN2021PTC142990 | Director | 21 Apr 2021 | 2021 | ₹18.3 Lakh (FY 2025) | Active |
| Future Biologics Private Limited U72100TN2026PTC195083 | Director | 09 Jul 2026 | 2026 | Active |
Board colleagues of Abdulpari Noorjahan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Myilsamy Rajesh | 09153772 | Biofocus Scientific Solutions Private Limited | Director |
| Nehru Pandian Anbukala | 09153783 | Biofocus Scientific Solutions Private Limited | Director |
| Iqbal Azim | 06578624 | Future Biologics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abdulpari Noorjahan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abdulpari Noorjahan
Abdulpari Noorjahan currently holds 2 directorships: Biofocus Scientific Solutions Private Limited (Director, since 21 Apr 2021, revenue ₹18.3 Lakh (FY 2025)); Future Biologics Private Limited (Director, since 09 Jul 2026).
Abdulpari Noorjahan was first appointed on 21 Apr 2021 as Director at Biofocus Scientific Solutions Private Limited. The most recent appointment on record is 09 Jul 2026 at Future Biologics Private Limited.
The current boards of Abdulpari Noorjahan's companies include Myilsamy Rajesh (Biofocus Scientific Solutions Private Limited), Nehru Pandian Anbukala (Biofocus Scientific Solutions Private Limited), Iqbal Azim (Future Biologics Private Limited).